Among the 34 gastric cancers, ADRA1B promoter methylation was detected in Region 1 in 12 cancers (35.3%), Region 2 in 14 (41.2%), Region 3 in 18 (52.9%), and Region 4 in 23 (67.6%). This evidence concerns the gene ADRA1B and gastric cancer.